 |
 |
|
|
As investment drives technology development, several life science trends are evident: genomics, biotechnology, and nanotechnology applications to medical device and healthcare markets; federal mandates for health record privacy and portability; and national efforts for universal, affordable healthcare. New technologies push the envelope of existing standards of care or drug/device performance, creating opportunities for new ventures with a strategic advantage.
Market Potential helps life science start-ups penetrate their key markets. We assist in the development of strategic plans, pricing strategy, partnership development, and financing options with the goal of building a sustainable market player. We specialize in firms with healthcare service concepts or medical and diagnostic devices.
Our four core services represent the key strategic tools our clients need to grow:
We design and implement market assessment tools to help our clients understand the value of their life science technology in specific healthcare market segments, the infrastructure requirements, the entry barriers, and the marketing approaches needed for success.
Market Potential provides its clients with critical information regarding their competitiveness in the marketplace, including the nature of their competition, their competitive advantage, and major trends that may change the competitive environment itself.
In the life sciences market partnerships are critical to a firm's success. We help our clients identify and develop the key partnerships and industry alliances they need to develop their technology, commercialize it, and penetrate targeted life science markets.
Market Potential can tap its network of life science investors, matching clients with investors appropriate for their product and market. For their investor presentations, we help clients optimize key aspects of their business to make their company attractive.
October, 2008 - Investment in life science ventures saw a 10% increase to $2.2 billion dollars in the 3rd quarter over the previous quarter. The increase in investment was primarily due to biotech investments, which were over $1.3 billion for the quarter, while medical device investments fell lower.
February, 2008 - Google announces in partnership with the Cleveland Clinic a pilot project to develop online tools for transferring electronic medical records online.
November, 2007 - Researchers in Kyoto University and the University of Wisconsin demonstrated separately they could turn skin cells into cells that acted like embryonic stem cells.
July, 2006 - California authorizes $150 million for stem cell research from Proposition 71 fund.